相关实验视频

Updated: Jun 30, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

DDX3通过3' UTR介导的PD-L1细胞表面表达来调节癌症免疫监测

Hung-Hsi Chen¹, Hsin-I Yu¹, Jason Jie-Sheng Chang¹

¹Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.

|March 15, 2024

概括

抑制RNA螺旋酶DDX3通过降低瘤细胞上的PD-L1来增强抗癌免疫力. 这种DDX3-AP2通路控制PD-L1细胞表面表达,提供了一个新的免疫治疗点.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

编程死亡-1 (PD-1) /PD-1 (PD-L1) 途径对于癌症免疫逃避至关重要.
向PD-1/PD-L1是一种成熟的抗癌免疫疗法策略.

研究的目的:

调查RNA螺旋酶DDX3在调节PD-L1表达和免疫细胞透在口腔状细胞癌中的作用.
阐明DDX3影响PD-L1细胞表面贩运的机制.

主要方法:

使用了同源性口腔状细胞癌瘤模型.
进行了DDX3敲击,并评估了CD8+ T细胞透.
研究了DDX3对干扰素γ诱导的PD-L1表达和细胞表面水平的影响.
研究了DDX3与PD-L1mRNA的3' UTR和AP2复合物的相互作用.
评估了破坏DDX3-AP2相互作用对PD-L1贩运的影响.

主要成果:

抑制DDX3增加了瘤中CD8+T细胞的透.
通过DDX3敲击,减少了干扰素γ诱导的PD-L1表达和细胞表面水平.
DDX3将AP2复合物招募到PD-L1mRNA 3' UTR中,从而促进细胞表面表达.
破坏DDX3-AP2相互作用降低了表面PD-L1水平.

结论:

在口腔状细胞癌中,DDX3-AP2通路对于将PD-L1路由到细胞表面至关重要.
准DDX3来调节免疫检查点蛋白贩运是一个潜在的癌症免疫治疗策略.

关键词:

3通过UTR介导的蛋白质与蛋白质相互作用.CP: 癌症癌症癌症 CP: 免疫学免疫学 YXXØØ YXXØØ 的意思是分类图案的分类图案.

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...